nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—SLC6A3—Parkinson's disease	0.819	1	CbGaD
Modafinil—Alverine—HTR1A—Parkinson's disease	0.00104	0.153	CrCbGaD
Modafinil—Benzphetamine—SLC18A2—Parkinson's disease	0.000865	0.127	CrCbGaD
Modafinil—Diphenylpyraline—SLC6A3—Parkinson's disease	0.000729	0.107	CrCbGaD
Modafinil—SLC6A3—telencephalic ventricle—Parkinson's disease	0.000583	0.197	CbGeAlD
Modafinil—Benzatropine—SLC6A3—Parkinson's disease	0.000559	0.0823	CrCbGaD
Modafinil—Bifonazole—CYP2E1—Parkinson's disease	0.000451	0.0663	CrCbGaD
Modafinil—SLC6A3—nerve—Parkinson's disease	0.000367	0.124	CbGeAlD
Modafinil—Benzphetamine—SLC6A3—Parkinson's disease	0.000359	0.0528	CrCbGaD
Modafinil—Atomoxetine—SLC6A3—Parkinson's disease	0.000356	0.0524	CrCbGaD
Modafinil—Cinnarizine—DRD2—Parkinson's disease	0.000298	0.0438	CrCbGaD
Modafinil—Benzatropine—CYP2D6—Parkinson's disease	0.000294	0.0432	CrCbGaD
Modafinil—SLC6A3—hindbrain—Parkinson's disease	0.000275	0.0932	CbGeAlD
Modafinil—Dextropropoxyphene—CYP2D6—Parkinson's disease	0.000215	0.0316	CrCbGaD
Modafinil—Cinnarizine—CYP2D6—Parkinson's disease	0.00021	0.031	CrCbGaD
Modafinil—Atomoxetine—HTR2A—Parkinson's disease	0.000205	0.0301	CrCbGaD
Modafinil—Orphenadrine—CYP2E1—Parkinson's disease	0.000195	0.0286	CrCbGaD
Modafinil—Atomoxetine—CYP2D6—Parkinson's disease	0.000187	0.0275	CrCbGaD
Modafinil—SLC6A3—brainstem—Parkinson's disease	0.000158	0.0534	CbGeAlD
Modafinil—SLC6A3—forebrain—Parkinson's disease	0.000152	0.0516	CbGeAlD
Modafinil—Fentanyl—ABCB1—Parkinson's disease	0.000152	0.0223	CrCbGaD
Modafinil—Diphenhydramine—CYP2D6—Parkinson's disease	0.000151	0.0222	CrCbGaD
Modafinil—Methadone—CYP2D6—Parkinson's disease	0.000146	0.0215	CrCbGaD
Modafinil—Carbamazepine—ABCB1—Parkinson's disease	0.000142	0.0209	CrCbGaD
Modafinil—Phenytoin—ABCB1—Parkinson's disease	0.000138	0.0203	CrCbGaD
Modafinil—ADRA1B—head—Parkinson's disease	0.000116	0.0394	CbGeAlD
Modafinil—ADRA1B—nervous system—Parkinson's disease	0.00011	0.0374	CbGeAlD
Modafinil—ADRA1B—central nervous system—Parkinson's disease	0.000106	0.036	CbGeAlD
Modafinil—Methadone—ABCB1—Parkinson's disease	0.000104	0.0153	CrCbGaD
Modafinil—SLC6A3—midbrain—Parkinson's disease	0.0001	0.034	CbGeAlD
Modafinil—SLC6A3—spinal cord—Parkinson's disease	9.8e-05	0.0332	CbGeAlD
Modafinil—SLC6A3—head—Parkinson's disease	8.71e-05	0.0295	CbGeAlD
Modafinil—ADRA1B—brain—Parkinson's disease	8.43e-05	0.0286	CbGeAlD
Modafinil—SLC6A3—nervous system—Parkinson's disease	8.26e-05	0.028	CbGeAlD
Modafinil—SLC6A3—central nervous system—Parkinson's disease	7.95e-05	0.0269	CbGeAlD
Modafinil—SLC6A3—cerebellum—Parkinson's disease	7.77e-05	0.0263	CbGeAlD
Modafinil—CYP2B6—cardiovascular system—Parkinson's disease	7.65e-05	0.0259	CbGeAlD
Modafinil—CYP2C9—cardiovascular system—Parkinson's disease	7.57e-05	0.0257	CbGeAlD
Modafinil—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	6.61e-05	0.000387	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	6.6e-05	0.000386	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	6.55e-05	0.000383	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—GRM5—Parkinson's disease	6.54e-05	0.000382	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NDUFB11—Parkinson's disease	6.52e-05	0.000381	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	6.52e-05	0.000381	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PPP1R1B—Parkinson's disease	6.44e-05	0.000377	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	6.37e-05	0.000373	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—EDN1—Parkinson's disease	6.36e-05	0.000372	CbGpPWpGaD
Modafinil—SLC6A3—brain—Parkinson's disease	6.31e-05	0.0214	CbGeAlD
Modafinil—CYP2B6—Metabolism—GCH1—Parkinson's disease	6.22e-05	0.000364	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	6.19e-05	0.000362	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.12e-05	0.000358	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.1e-05	0.000357	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GCH1—Parkinson's disease	6.08e-05	0.000356	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	6.08e-05	0.000355	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6e-05	0.000351	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	5.99e-05	0.000351	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	5.87e-05	0.000343	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.76e-05	0.000337	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RIT2—Parkinson's disease	5.63e-05	0.00033	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—HTR2A—Parkinson's disease	5.57e-05	0.000326	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—ADORA2A—Parkinson's disease	5.56e-05	0.000325	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—FBP1—Parkinson's disease	5.54e-05	0.000324	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—DBH—Parkinson's disease	5.54e-05	0.000324	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GBA—Parkinson's disease	5.54e-05	0.000324	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ND3—Parkinson's disease	5.53e-05	0.000323	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MCCC1—Parkinson's disease	5.53e-05	0.000323	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GBA—Parkinson's disease	5.42e-05	0.000317	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—DBH—Parkinson's disease	5.42e-05	0.000317	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—FBP1—Parkinson's disease	5.42e-05	0.000317	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	5.35e-05	0.000313	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GRK5—Parkinson's disease	5.34e-05	0.000312	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—HTR1A—Parkinson's disease	5.31e-05	0.000311	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—TAC1—Parkinson's disease	5.23e-05	0.000306	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TALDO1—Parkinson's disease	5.2e-05	0.000304	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—OMD—Parkinson's disease	5.2e-05	0.000304	CbGpPWpGaD
Modafinil—CYP2B6—head—Parkinson's disease	5.18e-05	0.0175	CbGeAlD
Modafinil—ADRA1B—GPCR downstream signaling—DRD1—Parkinson's disease	5.13e-05	0.0003	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.13e-05	0.0003	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.1e-05	0.000299	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.09e-05	0.000298	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.06e-05	0.000296	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ND3—Parkinson's disease	5.04e-05	0.000295	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MCCC1—Parkinson's disease	5.04e-05	0.000295	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.03e-05	0.000294	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—DRD3—Parkinson's disease	4.97e-05	0.000291	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	4.93e-05	0.000288	CbGpPWpGaD
Modafinil—CYP2B6—nervous system—Parkinson's disease	4.91e-05	0.0166	CbGeAlD
Modafinil—ADRA1B—Signaling by GPCR—HTR1A—Parkinson's disease	4.82e-05	0.000282	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GRM4—Parkinson's disease	4.79e-05	0.00028	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—TAC1—Parkinson's disease	4.75e-05	0.000278	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TALDO1—Parkinson's disease	4.74e-05	0.000277	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—OMD—Parkinson's disease	4.74e-05	0.000277	CbGpPWpGaD
Modafinil—CYP2B6—central nervous system—Parkinson's disease	4.73e-05	0.016	CbGeAlD
Modafinil—CYP2C19—Metabolism—GCH1—Parkinson's disease	4.7e-05	0.000275	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.69e-05	0.000274	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—DRD1—Parkinson's disease	4.66e-05	0.000272	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.64e-05	0.000271	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.62e-05	0.000271	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.57e-05	0.000268	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PENK—Parkinson's disease	4.54e-05	0.000266	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAG—Parkinson's disease	4.54e-05	0.000266	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—DRD3—Parkinson's disease	4.51e-05	0.000264	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	4.49e-05	0.000263	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—HTR7—Parkinson's disease	4.49e-05	0.000263	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—DRD2—Parkinson's disease	4.49e-05	0.000263	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ND3—Parkinson's disease	4.31e-05	0.000252	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MCCC1—Parkinson's disease	4.31e-05	0.000252	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GCH1—Parkinson's disease	4.29e-05	0.000251	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.24e-05	0.000248	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—ADRBK1—Parkinson's disease	4.21e-05	0.000246	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GBA—Parkinson's disease	4.19e-05	0.000245	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—DBH—Parkinson's disease	4.19e-05	0.000245	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—FBP1—Parkinson's disease	4.19e-05	0.000245	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PDYN—Parkinson's disease	4.15e-05	0.000243	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—HTR7—Parkinson's disease	4.08e-05	0.000239	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—DRD2—Parkinson's disease	4.08e-05	0.000239	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—DDC—Parkinson's disease	4.07e-05	0.000238	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TALDO1—Parkinson's disease	4.05e-05	0.000237	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—OMD—Parkinson's disease	4.05e-05	0.000237	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—DDC—Parkinson's disease	3.98e-05	0.000233	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GFAP—Parkinson's disease	3.9e-05	0.000228	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.87e-05	0.000226	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GRM5—Parkinson's disease	3.86e-05	0.000226	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTA4—Parkinson's disease	3.84e-05	0.000225	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	3.84e-05	0.000225	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GBA—Parkinson's disease	3.82e-05	0.000224	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—FBP1—Parkinson's disease	3.82e-05	0.000224	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—DBH—Parkinson's disease	3.82e-05	0.000224	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTA4—Parkinson's disease	3.76e-05	0.00022	CbGpPWpGaD
Modafinil—CYP2B6—brain—Parkinson's disease	3.75e-05	0.0127	CbGeAlD
Modafinil—CYP3A4—nervous system—Parkinson's disease	3.71e-05	0.0126	CbGeAlD
Modafinil—CYP1A2—Metabolism—GCH1—Parkinson's disease	3.66e-05	0.000214	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—EDN1—Parkinson's disease	3.6e-05	0.00021	CbGpPWpGaD
Modafinil—CYP3A4—central nervous system—Parkinson's disease	3.57e-05	0.0121	CbGeAlD
Modafinil—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	3.46e-05	0.000202	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	3.43e-05	0.0002	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MAOB—Parkinson's disease	3.43e-05	0.0002	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGF20—Parkinson's disease	3.39e-05	0.000198	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	3.38e-05	0.000198	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MAOB—Parkinson's disease	3.35e-05	0.000196	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.32e-05	0.000194	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ND3—Parkinson's disease	3.32e-05	0.000194	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.3e-05	0.000193	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ADORA2A—Parkinson's disease	3.28e-05	0.000192	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EDN1—Parkinson's disease	3.27e-05	0.000191	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—FBP1—Parkinson's disease	3.26e-05	0.000191	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GBA—Parkinson's disease	3.26e-05	0.000191	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—DBH—Parkinson's disease	3.26e-05	0.000191	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—HTR2A—Parkinson's disease	3.15e-05	0.000184	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—OMD—Parkinson's disease	3.13e-05	0.000183	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.13e-05	0.000183	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—DDC—Parkinson's disease	3.08e-05	0.00018	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—INSR—Parkinson's disease	3.03e-05	0.000177	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.96e-05	0.000173	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTA4—Parkinson's disease	2.9e-05	0.00017	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.87e-05	0.000168	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGB—Parkinson's disease	2.86e-05	0.000168	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—HTR2A—Parkinson's disease	2.86e-05	0.000167	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HTR1A—Parkinson's disease	2.85e-05	0.000167	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.83e-05	0.000165	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TAC1—Parkinson's disease	2.81e-05	0.000164	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—DDC—Parkinson's disease	2.8e-05	0.000164	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—DRD1—Parkinson's disease	2.75e-05	0.000161	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—DRD3—Parkinson's disease	2.66e-05	0.000156	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.65e-05	0.000155	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	2.61e-05	0.000153	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.61e-05	0.000153	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MAOB—Parkinson's disease	2.59e-05	0.000151	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	2.55e-05	0.000149	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.52e-05	0.000147	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GBA—Parkinson's disease	2.52e-05	0.000147	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—DBH—Parkinson's disease	2.52e-05	0.000147	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CTGF—Parkinson's disease	2.5e-05	0.000146	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	2.49e-05	0.000146	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	2.49e-05	0.000146	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.46e-05	0.000144	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CTGF—Parkinson's disease	2.44e-05	0.000143	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	2.41e-05	0.000141	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	2.41e-05	0.000141	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—DDC—Parkinson's disease	2.4e-05	0.00014	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	2.38e-05	0.000139	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MAOB—Parkinson's disease	2.36e-05	0.000138	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	2.33e-05	0.000136	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NQO1—Parkinson's disease	2.3e-05	0.000135	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	2.28e-05	0.000133	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—TH—Parkinson's disease	2.27e-05	0.000133	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTA4—Parkinson's disease	2.26e-05	0.000132	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NQO1—Parkinson's disease	2.25e-05	0.000132	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.25e-05	0.000131	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.23e-05	0.000131	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—TH—Parkinson's disease	2.22e-05	0.00013	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYCS—Parkinson's disease	2.18e-05	0.000127	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYCS—Parkinson's disease	2.13e-05	0.000125	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	2.04e-05	0.000119	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	2.02e-05	0.000118	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MAOB—Parkinson's disease	2.02e-05	0.000118	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	1.95e-05	0.000114	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—COMT—Parkinson's disease	1.93e-05	0.000113	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	1.93e-05	0.000113	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.92e-05	0.000113	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTP1—Parkinson's disease	1.92e-05	0.000112	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.92e-05	0.000112	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MAOA—Parkinson's disease	1.92e-05	0.000112	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—HMOX1—Parkinson's disease	1.89e-05	0.000111	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CTGF—Parkinson's disease	1.89e-05	0.00011	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—COMT—Parkinson's disease	1.89e-05	0.00011	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTP1—Parkinson's disease	1.88e-05	0.00011	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MAOA—Parkinson's disease	1.87e-05	0.00011	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—HMOX1—Parkinson's disease	1.85e-05	0.000108	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—DDC—Parkinson's disease	1.85e-05	0.000108	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ABCB1—Parkinson's disease	1.82e-05	0.000106	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ABCB1—Parkinson's disease	1.78e-05	0.000104	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	1.77e-05	0.000104	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTM1—Parkinson's disease	1.76e-05	0.000103	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.76e-05	0.000103	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.75e-05	0.000103	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.75e-05	0.000102	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NQO1—Parkinson's disease	1.74e-05	0.000102	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTM1—Parkinson's disease	1.72e-05	0.000101	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.72e-05	0.000101	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TH—Parkinson's disease	1.71e-05	0.0001	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GPX1—Parkinson's disease	1.69e-05	9.89e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	1.69e-05	9.87e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GPX1—Parkinson's disease	1.65e-05	9.66e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.65e-05	9.63e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.6e-05	9.39e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.59e-05	9.28e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.57e-05	9.2e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	1.57e-05	9.18e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TH—Parkinson's disease	1.56e-05	9.15e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MTHFR—Parkinson's disease	1.56e-05	9.12e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.56e-05	9.11e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MTHFR—Parkinson's disease	1.52e-05	8.92e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.5e-05	8.78e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.5e-05	8.77e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.47e-05	8.61e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—COMT—Parkinson's disease	1.46e-05	8.53e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOE—Parkinson's disease	1.45e-05	8.49e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.45e-05	8.49e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.45e-05	8.47e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.43e-05	8.37e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOE—Parkinson's disease	1.42e-05	8.3e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.37e-05	8.04e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.37e-05	8.02e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.36e-05	7.93e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—INS—Parkinson's disease	1.34e-05	7.84e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TH—Parkinson's disease	1.34e-05	7.82e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.33e-05	7.8e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—COMT—Parkinson's disease	1.33e-05	7.78e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.32e-05	7.74e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.32e-05	7.72e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.3e-05	7.63e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.28e-05	7.5e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.28e-05	7.47e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.25e-05	7.33e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—INS—Parkinson's disease	1.24e-05	7.26e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.22e-05	7.11e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—INS—Parkinson's disease	1.21e-05	7.09e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.18e-05	6.89e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.16e-05	6.81e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.16e-05	6.77e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—COMT—Parkinson's disease	1.14e-05	6.65e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.14e-05	6.64e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.13e-05	6.61e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.13e-05	6.6e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.11e-05	6.52e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOE—Parkinson's disease	1.1e-05	6.42e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.07e-05	6.29e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.07e-05	6.26e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.06e-05	6.19e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.05e-05	6.12e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.04e-05	6.08e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TH—Parkinson's disease	1.03e-05	6.03e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOE—Parkinson's disease	1e-05	5.85e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	9.98e-06	5.84e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GPX1—Parkinson's disease	9.95e-06	5.82e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	9.91e-06	5.8e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYCS—Parkinson's disease	9.9e-06	5.79e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—INS—Parkinson's disease	9.37e-06	5.48e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MTHFR—Parkinson's disease	9.18e-06	5.37e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	9.17e-06	5.37e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—COMT—Parkinson's disease	8.77e-06	5.13e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTP1—Parkinson's disease	8.73e-06	5.1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MAOA—Parkinson's disease	8.7e-06	5.09e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HMOX1—Parkinson's disease	8.61e-06	5.03e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOE—Parkinson's disease	8.55e-06	5e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—INS—Parkinson's disease	8.55e-06	5e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.26e-06	4.83e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.02e-06	4.69e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.68e-06	4.49e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—INS—Parkinson's disease	7.3e-06	4.27e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.09e-06	4.15e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOE—Parkinson's disease	6.6e-06	3.86e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	5.86e-06	3.43e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—INS—Parkinson's disease	5.64e-06	3.3e-05	CbGpPWpGaD
